Abstract 3912: ATM and PARP combined inhibition demonstrate synergistic antitumor efficacy in osteosarcoma models

骨肉瘤 癌症研究 肿瘤科 医学 化学 药理学
作者
Sona N. Kocinsky,Janeala J. Morsby,William C. Wright,Monika Wierdl,Caroline S. Wechsler,Gabriela Alexe,Paul Geeleher,Kimberly Stegmaier,Lillian M. Guenther
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (6_Supplement): 3912-3912
标识
DOI:10.1158/1538-7445.am2024-3912
摘要

Abstract Signatures of BRCAness are found in many osteosarcoma (OS) tumors, driving an interest in PARP inhibition (PARPi) for OS treatment. Although PARPi have shown limited efficacy as OS monotherapy, rational combination strategies have not yet been explored for this disease. We performed a genome-scale loss-of-function CRISPR-Cas9 screen in two OS cell lines in the presence and absence of olaparib, a small molecule PARPi. ATM knockout (KO) scored highly as a potent synergizer of PARPi across both cell lines. Here we report this screen finding as well as in vitro validation of PARPi and ATM inhibition (ATMi) synergy in OS models. OS cell lines SAOS2 and CAL72 were infected with the Avana genome-scale lentiviral CRISPR library, targeting 20,000 genes with 4 uniquely barcoded guides (sgRNAs) per gene. After infection and antibiotic selection, cells were grown in an IC40 dose of olaparib or matched control for 18 days. Following DNA sequencing of barcodes and rigorous quality control, sgRNA dropout hits were calculated against the control arm. ATM KO sensitizing to PARPi was first validated utilizing a CRISPR-based genetic approach. ATM KO in CAL72 and SAOS2 was performed via lentiviral infection. After KO confirmation by western immunoblotting (WB), ATM KO and control KO cells were treated with PARPi in a dose range of 19.5 nM-10 µM. ATP-based and Incucyte assays were used to quantify differential cell viability. Secondly, the combination of a small molecule ATMi and a PARPi was studied in a panel of OS cell lines. Synergistic cytotoxicity was quantified using the Zero Interaction Potency (ZIP) model. DNA damage levels after PARPi and ATMi (by chemical inhibition and genetic KO) were assessed by WB for γH2AX, a marker of DNA double-stranded breaks (DSBs). In our genome-scale CRISPR screens, ATM arose as a top druggable hit across both lines. Reassuringly, PARP1 KO scored as a top resistance mediator to PARPi, confirming biologic relevance of the screen and supporting the known PARP-trapping mechanism of these drugs in OS. At low-throughput, ATM KO lines trended toward increased sensitivity to PARPi in short-term viability assays. Combined chemical inhibition yielded highly synergistic ZIP scores across OS cell lines; synergy was achieved with both drugs in the low nanomolar range. γH2AX levels were substantially increased in the setting of combined PARPi and ATMi (via chemical inhibition or genetic KO) as compared to inactivation of either PARP or ATM alone, indicating increased presence of DNA DSBs. In conclusion, these data demonstrate synergy of ATM and PARP inhibition, providing promise for their potential combined use in the treatment of OS. Accumulation of DNA DSBs in response to PARP and ATM inactivation suggests a shared role in DNA damage repair as the molecular basis of synergism. Ongoing studies are investigating anti-tumor potential in in vivo OS models and exploring the mechanistic impact of the combination in OS tumors. Citation Format: Sona N. Kocinsky, Janeala J. Morsby, William C. Wright, Monika Wierdl, Caroline S. Wechsler, Gabriela Alexe, Paul Geeleher, Kimberly Stegmaier, Lillian M. Guenther. ATM and PARP combined inhibition demonstrate synergistic antitumor efficacy in osteosarcoma models [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3912.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhuxiaonian完成签到,获得积分10
2秒前
田様应助淘气科研采纳,获得10
2秒前
chenyi完成签到,获得积分10
3秒前
zyyyy完成签到,获得积分10
3秒前
奶黄包完成签到 ,获得积分10
3秒前
SYLH应助海阔天空采纳,获得10
3秒前
3秒前
机灵又蓝完成签到,获得积分10
4秒前
张土豆完成签到 ,获得积分10
4秒前
善学以致用应助小王采纳,获得10
4秒前
orang完成签到,获得积分10
5秒前
巧巧艾完成签到,获得积分10
5秒前
6秒前
邵洋完成签到,获得积分10
6秒前
sl发布了新的文献求助10
6秒前
7秒前
小迪迦奥特曼完成签到,获得积分10
7秒前
7秒前
cckk发布了新的文献求助10
8秒前
夏目由美完成签到 ,获得积分10
8秒前
Jasper应助哦哦哦采纳,获得10
9秒前
YYD完成签到,获得积分10
9秒前
超勍完成签到,获得积分10
9秒前
碧蓝碧凡发布了新的文献求助10
10秒前
Popeye应助鹤鸣采纳,获得30
10秒前
YYD发布了新的文献求助10
11秒前
yuanshl1985发布了新的文献求助10
11秒前
积极的黑猫完成签到,获得积分10
12秒前
GB完成签到 ,获得积分10
12秒前
Metx完成签到 ,获得积分10
13秒前
孤独的涔完成签到,获得积分10
14秒前
Jay完成签到,获得积分10
14秒前
15秒前
深情安青应助hf采纳,获得10
17秒前
学不懂数学应助大观天下采纳,获得10
17秒前
醉熏的水绿完成签到 ,获得积分10
17秒前
秦艺完成签到,获得积分10
18秒前
18秒前
18秒前
高高完成签到,获得积分20
19秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038426
求助须知:如何正确求助?哪些是违规求助? 3576119
关于积分的说明 11374556
捐赠科研通 3305834
什么是DOI,文献DOI怎么找? 1819339
邀请新用户注册赠送积分活动 892678
科研通“疑难数据库(出版商)”最低求助积分说明 815029